Thursday, May 23, 2013

EKOS Acquired By British Company

Seattle-based EKOS, the developer of ultrasound tools for treating vascular thrombosis, has been acquired by British biotech company BTG. BTG said it will pay $180M, plus up to $40M in earn out, for EKOS, whose products are used to treat severe blood clots. BTG said that the acquisition would be complementary to its interventional medicine business.